AMYLIN PHARMACEUTICALS INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
AMYLIN PHARMACEUTICALS INC reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $3.95 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-07.
Discontinued › Notes
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2012-05-07
- AMYLIN PHARMACEUTICALS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2012-03-31 was $3.95M.
- AMYLIN PHARMACEUTICALS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2011-03-31 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month |
|---|---|
| 2012-03-31 | $3.95M 10-Q · filed 2012-05-07 |
| 2011-03-31 | $0.00 10-Q · filed 2012-05-07 |